Skip to content

A clinical trial to study the comparation between a dentifrice with nano-hydroxyapatite formulation and diode laser alone and combination of both in the treatment of dentin hypersensitivity: A RCT

COMPARATIVE EVALUATION OF A DENTIFRICE WITH NANO-HYDROXYAPATITE FORMULATION AND DIODE LASER ALONE AND IN COMBINATION IN THE TREATMENT OF DENTIN HYPERSENSITIVITY: A RANDOMIZED CLINICAL TRIAL.

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/11/060130
Enrollment
60
Registered
2023-11-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K088- Other specified disorders of teethand supporting structures

Interventions

Intervention1: GROUP1-NANO-HAP 6.67% FORMULATED DENTIFRICE: The sites will be dried with an air blast and carefully isolated using cotton rolls. Pea -sized desensitizing agent will be taken on the app
Duration: 60 seconds with interval. Each site will be receiving two applications with a 10s interval between two consecutive applications of 30 seconds. Energy per application will be 4J/cm2. The opti

Sponsors

None
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects should be dentally mature in the age group of 19-60 years and have sensitive teeth with a clinical diagnosis satisfying the definition of dentin hypersensitivity. 2. Patient with at least one hypersensitive tooth following air blast, tactile test at the screening and baseline visit with baseline score >4. 3. Hypersensitivity located at facial aspects of the incisors, canines and premolars. 4. Patient complaining of sensitivity due to mechanical, thermal or chemical stimuli. 5. Early non-carious lesions including those which do not require restorations. 6. Loss of dentine should be less than 2mm deep as per tooth wear index. 7. Availability of the patient for the entire duration of the study.

Exclusion criteria

Exclusion criteria: 1. Systemic conditions that are etiological or predisposing to dentin hypersensitivity.( e.g. chronic acid regurgitation) 2. Medical and pharmacotherapeutic histories that may compromise the protocol including the chronic use of anti-inflammatory, analgesic and psychedelic drugs. 3. Benign or malignant pathological oral lesions. 4. Caries in the selected or adjacent teeth. 5. Teeth with non-carious lesions with pulpal involvement. 6. Congenital enamel or dentine defects. 7. Crazed or hypoplastic teeth. 8. Pregnancy or breast feeding. 9. Allergies and idiosyncratic responses to product ingredients. 10. Excessive dietary or environmental exposure to acids. 11. Eating disorders. 12. Periodontal surgery in preceding 3 months 13. Orthodontic appliance treatment within previous 3 months. 14. Teeth or supporting structures with any other painful pathology or defects. 15. Teeth to be restored. 16. Abutment teeth for fixed or removable prosthesis or crowned teeth. 17. Periodontal pockets. 18. Any professional desensitizing treatment in the last 3 months

Design outcomes

Primary

MeasureTime frame
Reduction in dentin hypersensitivityTimepoint: baseline, immediately after treatment, 1 week, 4 weeks and 8 weeks.

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Lisa Chacko

SMBT Dental College and Hospital,

lisabrahamj@gmail.com7378488875

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026